Therapeutic Potential of Intravenous Ketamine in Early-Onset Dementia: A Case Report.
Cureus July 1, 2024 Mariam Tadros, Dianella Rente Lavastida, Ashraf F Hanna 2 citations
This case report discusses the use of intravenous (IV) ketamine as a potential therapeutic agent for early-onset dementia. A 56-year-old female with a diagnosis of early-onset dementia showed significant cognitive decline despite trying and failing several standard treatments such as memantine, donepezil, and rivastigmine. Given the promising results of ketamine in other neurological and...